Market Currents
Abbott Labs (ABT +0.5%) launches its XIENCE Xpedition drug-eluting coronary stent, which slowly...
-
Thursday, January 3, 9:00 AM ETAbbott Labs (ABT +0.5%) launches its XIENCE Xpedition drug-eluting coronary stent, which slowly releases a medicine to block cell proliferation, after receiving FDA approval for the device. "XIENCE Xpedition represents a powerful combination of deliverability, strong clinical data and broad availability of meaningful sizes," says Dr Samin Sharma of Mount Sinai Medical Center in New York. (PR)
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
